Free Trial

Docusign (NASDAQ:DOCU) CFO Blake Jeffrey Grayson Sells 9,509 Shares

Docusign logo with Computer and Technology background

Key Points

  • Docusign CFO Blake Jeffrey Grayson sold 9,509 shares at an average price of $83.10, totaling approximately $790,198, which represents a 7.82% decrease in his position.
  • The company reported $800.64 million in revenue for the last quarter, exceeding estimates and achieving an 8.8% year-over-year growth.
  • Docusign has a stock repurchase program approved for up to $1 billion, indicating management's belief that the shares are undervalued.
  • MarketBeat previews the top five stocks to own by October 1st.

Docusign Inc. (NASDAQ:DOCU - Get Free Report) CFO Blake Jeffrey Grayson sold 9,509 shares of Docusign stock in a transaction dated Wednesday, September 17th. The stock was sold at an average price of $83.10, for a total value of $790,197.90. Following the completion of the sale, the chief financial officer owned 112,160 shares of the company's stock, valued at $9,320,496. The trade was a 7.82% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website.

Docusign Price Performance

NASDAQ DOCU traded down $0.42 during trading hours on Friday, hitting $84.59. The company's stock had a trading volume of 4,516,106 shares, compared to its average volume of 2,700,885. Docusign Inc. has a 12 month low of $57.58 and a 12 month high of $107.86. The company's 50 day simple moving average is $76.17 and its two-hundred day simple moving average is $79.28. The company has a market cap of $17.01 billion, a P/E ratio of 63.60, a price-to-earnings-growth ratio of 4.43 and a beta of 1.02.

Docusign (NASDAQ:DOCU - Get Free Report) last released its quarterly earnings data on Thursday, September 4th. The company reported $0.92 EPS for the quarter, topping the consensus estimate of $0.84 by $0.08. Docusign had a return on equity of 14.01% and a net margin of 9.08%.The company had revenue of $800.64 million during the quarter, compared to the consensus estimate of $780.35 million. During the same period last year, the company earned $0.97 EPS. Docusign's revenue for the quarter was up 8.8% on a year-over-year basis. Docusign has set its Q3 2026 guidance at EPS. FY 2026 guidance at EPS. As a group, research analysts predict that Docusign Inc. will post 1.17 earnings per share for the current fiscal year.

Docusign announced that its board has approved a stock repurchase program on Thursday, June 5th that allows the company to repurchase $1.00 billion in shares. This repurchase authorization allows the company to purchase up to 6.6% of its stock through open market purchases. Stock repurchase programs are often a sign that the company's board believes its shares are undervalued.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in DOCU. Norges Bank purchased a new position in shares of Docusign during the 2nd quarter valued at about $140,987,000. Wellington Management Group LLP lifted its position in shares of Docusign by 372.5% during the 1st quarter. Wellington Management Group LLP now owns 1,826,949 shares of the company's stock valued at $148,714,000 after buying an additional 1,440,269 shares in the last quarter. Duquesne Family Office LLC purchased a new position in shares of Docusign during the 1st quarter valued at about $87,477,000. Pacer Advisors Inc. lifted its position in shares of Docusign by 809.6% during the 1st quarter. Pacer Advisors Inc. now owns 1,167,290 shares of the company's stock valued at $95,017,000 after buying an additional 1,038,962 shares in the last quarter. Finally, Third Point LLC purchased a new position in shares of Docusign during the 2nd quarter valued at about $48,681,000. 77.64% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several equities research analysts recently commented on the company. Wells Fargo & Company lifted their price objective on Docusign from $80.00 to $85.00 and gave the stock an "equal weight" rating in a report on Friday, September 5th. Wedbush cut their price target on Docusign from $100.00 to $85.00 and set a "neutral" rating for the company in a research note on Thursday, June 12th. Robert W. Baird boosted their price target on Docusign from $85.00 to $90.00 and gave the company a "neutral" rating in a research note on Friday, September 5th. Wall Street Zen upgraded Docusign from a "hold" rating to a "buy" rating in a research note on Saturday, September 13th. Finally, JPMorgan Chase & Co. boosted their price target on Docusign from $77.00 to $80.00 and gave the company a "neutral" rating in a research note on Friday, September 5th. One research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and fourteen have given a Hold rating to the stock. According to MarketBeat, the company has a consensus rating of "Hold" and a consensus target price of $94.14.

Get Our Latest Analysis on DOCU

Docusign Company Profile

(Get Free Report)

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.

Read More

Insider Buying and Selling by Quarter for Docusign (NASDAQ:DOCU)

Should You Invest $1,000 in Docusign Right Now?

Before you consider Docusign, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Docusign wasn't on the list.

While Docusign currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.